Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Y Scarabin

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Climacteric : the Journal of the International Menopause Society|September 17, 2014
Hormones and venous thromboembolism among postmenopausal womenP-Y Scarabin
La Revue De Medecine Interne|April 23, 2003
[Does hormone replacement therapy in menopause have a cardiovascular benefit?]P-Y Scarabin
La Revue De Medecine Interne|May 12, 2001
[Hormone replacement therapy in menopause and cardiovascular risks]P Y Scarabin
Revue D'Epidemiologie Et De Sante Publique|April 1, 1996
[A new generation of oral contraceptives and venous thromboembolic diseases: unexpected results!]P Y Scarabin
Climacteric : the Journal of the International Menopause Society|March 24, 2018
Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysisP-Y Scarabin
Revue D'Epidemiologie Et De Sante Publique|January 31, 1998
[Hormone replacement therapy of menopause and mortality]P Y Scarabin
Lancet (London, England)|December 14, 1996
Risk of venous thrombosis with hormone replacement therapyP Y Scarabin
Annales D'Endocrinologie|October 16, 1999
[Hormone replacement therapy in menopause and the risk of cerebrovascular accident]E Oger, P Y Scarabin
Thrombosis Research|June 1, 1981
Effect of age on ADP-induced platelet aggregation in diabetic and non-diabetic subjectsP Y Scarabin, M Samama
American Journal of Epidemiology|February 2, 1999
Re: "Hormone replacement therapy and risk of hospitalization for venous thromboembolism: a population-based study in southern Europe"E Oger, P Y Scarabin
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Climacteric : the Journal of the International Menopause Society|September 17, 2014
Hormones and venous thromboembolism among postmenopausal womenP-Y Scarabin
La Revue De Medecine Interne|April 23, 2003
[Does hormone replacement therapy in menopause have a cardiovascular benefit?]P-Y Scarabin
La Revue De Medecine Interne|May 12, 2001
[Hormone replacement therapy in menopause and cardiovascular risks]P Y Scarabin
Revue D'Epidemiologie Et De Sante Publique|April 1, 1996
[A new generation of oral contraceptives and venous thromboembolic diseases: unexpected results!]P Y Scarabin
Climacteric : the Journal of the International Menopause Society|March 24, 2018
Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysisP-Y Scarabin
Revue D'Epidemiologie Et De Sante Publique|January 31, 1998
[Hormone replacement therapy of menopause and mortality]P Y Scarabin
Lancet (London, England)|December 14, 1996
Risk of venous thrombosis with hormone replacement therapyP Y Scarabin
Annales D'Endocrinologie|October 16, 1999
[Hormone replacement therapy in menopause and the risk of cerebrovascular accident]E Oger, P Y Scarabin
Thrombosis Research|June 1, 1981
Effect of age on ADP-induced platelet aggregation in diabetic and non-diabetic subjectsP Y Scarabin, M Samama
American Journal of Epidemiology|February 2, 1999
Re: "Hormone replacement therapy and risk of hospitalization for venous thromboembolism: a population-based study in southern Europe"E Oger, P Y Scarabin
Pageof 7